{"recordCount":46,"candidates":[{"candidate_id":"ipatasertib-akt1","display_id":null,"title":"Ipatasertib → AKT1 (PI3Kα→AKT1 axis node)","question":"Ipatasertib → AKT1 (PI3Kα→AKT1 axis node)","targets":["AKT1"],"biomarkers":[],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/ipatasertib-akt1"},{"candidate_id":"capivasertib-akt1","display_id":null,"title":"Capivasertib → AKT1 (PI3Kα→AKT1 axis node)","question":"Capivasertib → AKT1 (PI3Kα→AKT1 axis node)","targets":["AKT1"],"biomarkers":[],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/capivasertib-akt1"},{"candidate_id":"copanlisib-pik3ca-canine","display_id":null,"title":"Copanlisib warhead → canine PIK3CA (PROTAC warhead)","question":"Copanlisib warhead → canine PIK3CA (PROTAC warhead)","targets":["PIK3CA_CANINE"],"biomarkers":[],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/copanlisib-pik3ca-canine"},{"candidate_id":"taselisib-pik3ca-canine","display_id":null,"title":"Taselisib → canine PIK3CA (degrader engagement)","question":"Taselisib → canine PIK3CA (degrader engagement)","targets":["PIK3CA_CANINE"],"biomarkers":[],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/taselisib-pik3ca-canine"},{"candidate_id":"inavolisib-pik3ca-canine","display_id":null,"title":"Inavolisib → canine PIK3CA (degrader engagement)","question":"Inavolisib → canine PIK3CA (degrader engagement)","targets":["PIK3CA_CANINE"],"biomarkers":[],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/inavolisib-pik3ca-canine"},{"candidate_id":"stx478-pik3ca","display_id":null,"title":"STX-478 (mutant-selective allosteric PI3Ka) × PIK3CA","question":"STX-478 (mutant-selective allosteric PI3Ka) × PIK3CA","targets":["PIK3CA"],"biomarkers":["PIK3CA H1047R","PIK3CA E545K"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/stx478-pik3ca"},{"candidate_id":"zstk474-pik3ca","display_id":null,"title":"ZSTK474 (PI3K-PROTAC warhead) × PIK3CA","question":"ZSTK474 (PI3K-PROTAC warhead) × PIK3CA","targets":["PIK3CA"],"biomarkers":["PIK3CA"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/zstk474-pik3ca"},{"candidate_id":"genistein-pik3ca","display_id":null,"title":"Falsify: does genistein engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does genistein engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PI3K/AKT pathway"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/genistein-pik3ca"},{"candidate_id":"sorafenib-vegfr2","display_id":null,"title":"Falsify: does sorafenib engage KDR in canine HSA × human angiosarcoma?","question":"Does sorafenib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/sorafenib-vegfr2"},{"candidate_id":"cediranib-vegfr2","display_id":null,"title":"Falsify: does cediranib engage KDR in canine HSA × human angiosarcoma?","question":"Does cediranib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression","angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/cediranib-vegfr2"},{"candidate_id":"motesanib-vegfr2","display_id":null,"title":"Falsify: does motesanib engage KDR in canine HSA × human angiosarcoma?","question":"Does motesanib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/motesanib-vegfr2"},{"candidate_id":"tivozanib-vegfr2","display_id":null,"title":"Falsify: does tivozanib engage KDR in canine HSA × human angiosarcoma?","question":"Does tivozanib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/tivozanib-vegfr2"},{"candidate_id":"vandetanib-vegfr2","display_id":null,"title":"Falsify: does vandetanib engage KDR in canine HSA × human angiosarcoma?","question":"Does vandetanib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/vandetanib-vegfr2"},{"candidate_id":"nintedanib-vegfr2","display_id":null,"title":"Falsify: does nintedanib engage KDR in canine HSA × human angiosarcoma?","question":"Does nintedanib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression","angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/nintedanib-vegfr2"},{"candidate_id":"dactolisib-pik3ca","display_id":null,"title":"Falsify: does dactolisib engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does dactolisib engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PI3K/mTOR pathway"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/dactolisib-pik3ca"},{"candidate_id":"lenvatinib-vegfr2","display_id":null,"title":"Falsify: does lenvatinib engage KDR in canine HSA × human angiosarcoma?","question":"Does lenvatinib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression","angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/lenvatinib-vegfr2"},{"candidate_id":"cabozantinib-vegfr2","display_id":null,"title":"Falsify: does cabozantinib engage KDR in canine HSA × human angiosarcoma?","question":"Does cabozantinib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/cabozantinib-vegfr2"},{"candidate_id":"serabelisib-pik3ca","display_id":null,"title":"Falsify: does serabelisib engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does serabelisib engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PIK3CA mutation"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/serabelisib-pik3ca"},{"candidate_id":"gedatolisib-pik3ca","display_id":null,"title":"Falsify: does gedatolisib engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does gedatolisib engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PI3K/mTOR pathway"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/gedatolisib-pik3ca"},{"candidate_id":"duvelisib-pik3ca","display_id":null,"title":"Falsify: does duvelisib engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does duvelisib engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PI3K pathway activation"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/duvelisib-pik3ca"},{"candidate_id":"copanlisib-pik3ca","display_id":null,"title":"Falsify: does copanlisib engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does copanlisib engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PIK3CA mutation","PI3K pathway activation"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/copanlisib-pik3ca"},{"candidate_id":"taselisib-pik3ca","display_id":null,"title":"Falsify: does taselisib engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does taselisib engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PIK3CA mutation"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/taselisib-pik3ca"},{"candidate_id":"pictilisib-pik3ca","display_id":null,"title":"Falsify: does pictilisib engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does pictilisib engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PI3K pathway activation"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/pictilisib-pik3ca"},{"candidate_id":"inavolisib-pik3ca","display_id":null,"title":"Falsify: does inavolisib engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does inavolisib engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PIK3CA mutation"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/inavolisib-pik3ca"},{"candidate_id":"sunitinib-vegfr2","display_id":null,"title":"Falsify: does sunitinib engage KDR in canine HSA × human angiosarcoma?","question":"Does sunitinib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression","angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/sunitinib-vegfr2"},{"candidate_id":"pazopanib-vegfr2","display_id":null,"title":"Falsify: does pazopanib engage KDR in canine HSA × human angiosarcoma?","question":"Does pazopanib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression","angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/pazopanib-vegfr2"},{"candidate_id":"axitinib-vegfr2","display_id":null,"title":"Falsify: does axitinib engage KDR in canine HSA × human angiosarcoma?","question":"Does axitinib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/axitinib-vegfr2"},{"candidate_id":"regorafenib-vegfr2","display_id":null,"title":"Falsify: does regorafenib engage KDR in canine HSA × human angiosarcoma?","question":"Does regorafenib engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression","angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/regorafenib-vegfr2"},{"candidate_id":"toceranib-vegfr2","display_id":null,"title":"Toceranib (VEGFR2/KDR inhibitor) for angiogenesis-driven hemangiosarcoma","question":"Toceranib (VEGFR2/KDR inhibitor) for angiogenesis-driven hemangiosarcoma","targets":["KDR"],"biomarkers":["VEGFR2 expression","tumor angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/toceranib-vegfr2"},{"candidate_id":"alpelisib-pi3ka","display_id":null,"title":"Alpelisib (PI3Ka inhibitor) for PIK3CA-driven hemangiosarcoma","question":"Alpelisib (PI3Ka inhibitor) for PIK3CA-driven hemangiosarcoma","targets":["PIK3CA"],"biomarkers":["PIK3CA mutation"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/alpelisib-pi3ka"},{"candidate_id":"mebendazole-vegfr2","display_id":null,"title":"Falsify: does mebendazole engage KDR in canine HSA × human angiosarcoma?","question":"Does mebendazole engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["angiogenesis","VEGFR2 expression"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"still-standing","payload_url":"/api/public-candidates/mebendazole-vegfr2"},{"candidate_id":"rly2608-pik3ca","display_id":null,"title":"RLY-2608 (mutant-selective allosteric PI3Ka) × PIK3CA","question":"RLY-2608 (mutant-selective allosteric PI3Ka) × PIK3CA","targets":["PIK3CA"],"biomarkers":["PIK3CA H1047R","PIK3CA E545K"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"needs-more","payload_url":"/api/public-candidates/rly2608-pik3ca"},{"candidate_id":"cnx1351-pik3ca","display_id":null,"title":"CNX-1351 (covalent PI3Ka, Cys862) × PIK3CA","question":"CNX-1351 (covalent PI3Ka, Cys862) × PIK3CA","targets":["PIK3CA"],"biomarkers":["PIK3CA"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"needs-more","payload_url":"/api/public-candidates/cnx1351-pik3ca"},{"candidate_id":"prn1371-kdr","display_id":null,"title":"PRN1371 (covalent kinase tool, VEGFR2 engagement) × KDR","question":"PRN1371 (covalent kinase tool, VEGFR2 engagement) × KDR","targets":["KDR"],"biomarkers":["angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"needs-more","payload_url":"/api/public-candidates/prn1371-kdr"},{"candidate_id":"pik3ca-immunosuppression-crux","display_id":null,"title":"Is the PIK3CA-mutant HSA subset immunosuppressed? (TME deconvolution crux)","question":"Is the PIK3CA-mutant HSA subset immunosuppressed? (TME deconvolution crux)","targets":["PIK3CA"],"biomarkers":["TME immune composition","tumor purity"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"needs-more","payload_url":"/api/public-candidates/pik3ca-immunosuppression-crux"},{"candidate_id":"carvedilol-vegfr2","display_id":null,"title":"Falsify: does carvedilol engage KDR in canine HSA × human angiosarcoma?","question":"Does carvedilol engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/carvedilol-vegfr2"},{"candidate_id":"losartan-vegfr2","display_id":null,"title":"Falsify: does losartan engage KDR in canine HSA × human angiosarcoma?","question":"Does losartan engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["angiogenesis","TGFbeta"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/losartan-vegfr2"},{"candidate_id":"nelfinavir-vegfr2","display_id":null,"title":"Falsify: does nelfinavir engage KDR in canine HSA × human angiosarcoma?","question":"Does nelfinavir engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/nelfinavir-vegfr2"},{"candidate_id":"nelfinavir-pik3ca","display_id":null,"title":"Falsify: does nelfinavir engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does nelfinavir engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PI3K/AKT pathway"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/nelfinavir-pik3ca"},{"candidate_id":"perphenazine-pik3ca","display_id":null,"title":"Falsify: does perphenazine engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does perphenazine engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PP2A","AKT pathway"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/perphenazine-pik3ca"},{"candidate_id":"trifluoperazine-pik3ca","display_id":null,"title":"Falsify: does trifluoperazine engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does trifluoperazine engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["AKT pathway"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/trifluoperazine-pik3ca"},{"candidate_id":"honokiol-pik3ca","display_id":null,"title":"Falsify: does honokiol engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does honokiol engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PI3K/AKT/mTOR pathway"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/honokiol-pik3ca"},{"candidate_id":"valproic-acid-pik3ca","display_id":null,"title":"Falsify: does valproic acid engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does valproic acid engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["HDAC","PI3K pathway"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/valproic-acid-pik3ca"},{"candidate_id":"sulforaphane-pik3ca","display_id":null,"title":"Falsify: does sulforaphane engage PIK3CA in canine HSA × human angiosarcoma?","question":"Does sulforaphane engage PIK3CA in canine HSA × human angiosarcoma?","targets":["PIK3CA"],"biomarkers":["PI3K/AKT pathway"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/sulforaphane-pik3ca"},{"candidate_id":"propranolol-vegfr2","display_id":null,"title":"Falsify: does propranolol engage KDR in canine HSA × human angiosarcoma?","question":"Does propranolol engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["VEGFR2 expression","angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/propranolol-vegfr2"},{"candidate_id":"fenofibrate-vegfr2","display_id":null,"title":"Falsify: does fenofibrate engage KDR in canine HSA × human angiosarcoma?","question":"Does fenofibrate engage KDR in canine HSA × human angiosarcoma?","targets":["KDR"],"biomarkers":["angiogenesis"],"public_status":"evidence_supported","validation_ready":true,"priority_score":0.5,"kind":"target_strategy","verdict":"ruled-out","payload_url":"/api/public-candidates/fenofibrate-vegfr2"}]}